一、依據衛生福利部食品藥物管理署115年11月3日FDA管字第1151800514號函及教育部115年11月11日臺教學(五)字第1150113429號函辦理。
二、坊間所稱「聰明藥」（成分為 Methylphenidate）屬第三級管制藥品，限供醫藥及科學上需用，否則即屬毒品，民眾如有疾病所需，須經醫師診療後方能憑其處方調劑供應。
三、請加強對學校教職員工、學生及家長宣導，並提醒切勿私下流通、交易或贈送管制藥品，以免觸法。
四、如發現疑涉非法供應管制藥品等不法情事，請依相關法令及權責，移請檢警調等相關機關依法偵辦。

1. This notice is issued in accordance with the letter from the Taiwan Food and Drug Administration, Ministry of Health and Welfare, dated November 3, 2026 (Ref. No. FDA-Controlled-1151800514), and the letter from the Ministry of Education dated November 11, 2026 (Ref. No. Tai-Jiao-Xue (5) 1150113429).

2. The so-called “smart drug” commonly available on the market, which contains the active ingredient Methylphenidate, is classified as a Schedule III controlled drug and is restricted to medical and scientific use. Any use outside these authorized purposes is considered illegal and may constitute a drug-related offense. Individuals who require this medication for medical reasons must first undergo a medical evaluation by a physician and obtain a valid prescription before it can be dispensed.

3. Please strengthen awareness campaigns targeting school faculty and staff, students, and parents. Remind everyone not to privately distribute, trade, or give away controlled drugs, as doing so may violate the law.

4. If any suspected illegal supply or other unlawful activities involving controlled drugs are discovered, please refer the matter to the appropriate law enforcement or investigative authorities for investigation and handling in accordance with relevant laws and regulations and their respective responsibilities.